Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Pearson 2011 Statutory Pre-tax Profit Up - Quick Facts

Pearson Plc's (PSON.L,PSO: Quote) full-year 2011 statutory pre-tax profit advanced to 1.15 billion pounds from 670 million pounds in 2010, while profit attributable to equity holders of the company declining to 957 million pounds from prior year's 1.30 billion pounds.

Statutory earnings per share for the full year were 119.3 pence, considerably lower than 161.5 pence a year earlier. However, on an adjusted basis, earnings per share grew to 86.5 pence from 77.5 pence last year.

On a headline basis, sales on continuing operations totaled 5.86 billion pounds, a 4% increase from 5.66 billion pounds a year earlier. Sales, on an underlying basis, rose by 1% in 2011 versus 2010.

Click here to receive FREE breaking news email alerts for Pearson PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.